Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Fujimura

Showing results (371-380 of 383) with videos related to

Pageof 39
Sort By:
World Neurosurgery|December 16, 2024
Treatment of Unruptured Large and Giant Paraclinoid Aneurysms in Japan at the Time of Flow Diverter Introduction: A Nationwide, Multicenter Survey by the Japanese Society on Surgery for Cerebral StrokeKazuya Kanemaru, Hideyuki Yoshioka, Koji Hashimoto, et al.
Journal of Neurosurgery|May 14, 2025
Disease progression, transient ischemic attack, and de novo parenchymal lesions in asymptomatic moyamoya disease: results of a 5-year interim analysis of the AMORE studySatoshi Kuroda, Shusuke Yamamoto, Takeshi Funaki, et al.
Neurotrauma Reports|February 24, 2025
Relationship Between Location of Cell Transplantation and Recovery for Intracerebral Stem Cell Transplantation for Chronic Traumatic Brain Injury: <i>Post-hoc</i> Analysis of STEMTRA TrialMasahito Kawabori, Yasuaki Karasawa, Jun Suenaga, et al.
Med (New York, N.Y.)|March 28, 2024
Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic strokeMasahito Kawabori, Satoshi Kuroda, Hideo Shichinohe, et al.
Journal of Human Genetics|November 5, 2010
A genome-wide association study identifies RNF213 as the first Moyamoya disease geneFumiaki Kamada, Yoko Aoki, Ayumi Narisawa, et al.
Frontiers in Oncology|May 17, 2024
Clinical outcomes for olfactory neuroblastomaAkira Nakazono, Hiroaki Motegi, Masanobu Suzuki, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 30, 2026
The AMORE score for predicting the 5-year risk of hemorrhagic stroke in asymptomatic moyamoya diseaseTomohito Hishikawa, Satoshi Murai, Yoichi M Ito, et al.
JAMA Neurology|January 16, 2024
Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical TrialKiyohiro Houkin, Toshiya Osanai, Shinichiro Uchiyama, et al.
Neurologia Medico-Chirurgica|May 17, 2026
Practical Guide to Clazosentan Administration in Patients with Aneurysmal Subarachnoid HemorrhageHidenori Suzuki, Yosuke Akamatsu, Hiroshi Abe, et al.
Journal of Neurosurgery. Pediatrics|February 20, 2026
Unique clinical and radiological features in patients with moyamoya disease under 4 years of age: a multicenter MACINTOSH Study in JapanSatoshi Kuroda, Shoko Hara, Takeshi Funaki, et al.
Pageof 39

Showing results (371-380 of 383) with videos related to

Sort By:
Pageof 39
World Neurosurgery|December 16, 2024
Treatment of Unruptured Large and Giant Paraclinoid Aneurysms in Japan at the Time of Flow Diverter Introduction: A Nationwide, Multicenter Survey by the Japanese Society on Surgery for Cerebral StrokeKazuya Kanemaru, Hideyuki Yoshioka, Koji Hashimoto, et al.
Journal of Neurosurgery|May 14, 2025
Disease progression, transient ischemic attack, and de novo parenchymal lesions in asymptomatic moyamoya disease: results of a 5-year interim analysis of the AMORE studySatoshi Kuroda, Shusuke Yamamoto, Takeshi Funaki, et al.
Neurotrauma Reports|February 24, 2025
Relationship Between Location of Cell Transplantation and Recovery for Intracerebral Stem Cell Transplantation for Chronic Traumatic Brain Injury: <i>Post-hoc</i> Analysis of STEMTRA TrialMasahito Kawabori, Yasuaki Karasawa, Jun Suenaga, et al.
Med (New York, N.Y.)|March 28, 2024
Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic strokeMasahito Kawabori, Satoshi Kuroda, Hideo Shichinohe, et al.
Journal of Human Genetics|November 5, 2010
A genome-wide association study identifies RNF213 as the first Moyamoya disease geneFumiaki Kamada, Yoko Aoki, Ayumi Narisawa, et al.
Frontiers in Oncology|May 17, 2024
Clinical outcomes for olfactory neuroblastomaAkira Nakazono, Hiroaki Motegi, Masanobu Suzuki, et al.
Cerebrovascular Diseases (Basel, Switzerland)|January 30, 2026
The AMORE score for predicting the 5-year risk of hemorrhagic stroke in asymptomatic moyamoya diseaseTomohito Hishikawa, Satoshi Murai, Yoichi M Ito, et al.
JAMA Neurology|January 16, 2024
Allogeneic Stem Cell Therapy for Acute Ischemic Stroke: The Phase 2/3 TREASURE Randomized Clinical TrialKiyohiro Houkin, Toshiya Osanai, Shinichiro Uchiyama, et al.
Neurologia Medico-Chirurgica|May 17, 2026
Practical Guide to Clazosentan Administration in Patients with Aneurysmal Subarachnoid HemorrhageHidenori Suzuki, Yosuke Akamatsu, Hiroshi Abe, et al.
Journal of Neurosurgery. Pediatrics|February 20, 2026
Unique clinical and radiological features in patients with moyamoya disease under 4 years of age: a multicenter MACINTOSH Study in JapanSatoshi Kuroda, Shoko Hara, Takeshi Funaki, et al.
Pageof 39